Schering's Eulexin (flutamide)
Executive Summary
Schering's Eulexin (flutamide): Anticancer compound is not yet approved in the U.S. ("The Pink Sheet" July 18, T&G-10). However, FDA's Oncologic Drugs Advisory committee agreed at its Feb. 25-26 meeting that the product shows some increase in progression-free survival in prostate cancer patients.